2,309
Views
9
CrossRef citations to date
0
Altmetric
Research Articles

Unburdening dementia – a basic social process grounded theory based on a primary care physician survey from 25 countries

, , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 253-264 | Received 27 Oct 2019, Accepted 07 Jun 2020, Published online: 28 Jul 2020

References

  • Singer M, Bulled N, Ostrach B, et al. Syndemics and the biosocial conception of health. Lancet. 2017;389(10072):941–950.
  • Iliffe S, Manthorpe J. Dementia: is the biopsychosocial model vindicated? Br J Gen Pract. 2017;67(661):344–345.
  • Glynn LG, Valderas JM, Healy P, et al. The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Fam Pract. 2011;28(5):516–523.
  • Schmidt-Mende K, Hasselström J, Wettermark B, et al. General practitioners' and nurses' views on medication reviews and potentially inappropriate medicines in elderly patients - a qualitative study of reports by educating pharmacists. Scand J Prim Health Care. 2018;36(3):329–341.
  • Clegg A, Young J, Iliffe S, et al. Frailty in elderly people. Lancet. 2013;381(9868):752–762.
  • Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113):2673–2734.
  • Cheng ST. Dementia caregiver burden: a research update and critical analysis. Curr Psychiatry Rep. 2017;19(9):64.
  • Koch T, Iliffe S, Project E-E, EVIDEM-ED project. Rapid appraisal of barriers to the diagnosis and management of patients with dementia in primary care: a systematic review. BMC Fam Pract. 2010;11:52.
  • Petrazzuoli F, Vinker S, Koskela TH, et al. Exploring dementia management attitudes in primary care: a key informant survey to primary care physicians in 25 European countries. Int Psychogeriatr. 2017;29(9):1413–1423.
  • Petrazzuoli F. Dementia management in European primary care. [Dissertation]. Lund: Lund University: Faculty of Medicine, 2019. 107 p. https://portal.research.lu.se/portal/files/64009821/Ferdinando_Petrazzuoli_WEBB_1_.pdf. (accessed 22 February 2020)
  • Glaser B, Strauss AL. The discovery of grounded theory: strategies for qualitative research. New Brunswick, NJ: Aldine; 1967.
  • Glaser BG. Doing quantitative grounded theory. Mill Valley, CA: Sociology Press; 2008.
  • Holton JA, Walsh I. Classic grounded theory: applications with qualitative and quantitative data. Newbury Park, CA: Sage; 2017.
  • Glaser BG. Doing grounded theory: issues and discussions. Mill Valley, CA: Sociology Press; 1998.
  • Glaser BG, Holton J. Basic social processes. Grounded theory review. 2005;4:1–29.
  • Glaser BG. Theoretical sensitivity: advances in the methodology of grounded theory. Mill Valley, CA: Sociology Press; 1978.
  • Reeve E, Farrell B, Thompson W, et al. Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary. Med J Aust. 2019;210(4):174–179.
  • O'Brien JT, Holmes C, Jones M, et al. Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology. J Psychopharmacol (Oxford)). 2017;31(2):147–168.
  • Association AP. Diagnostic and statistical manual of mental disorders (DSM-5®). Washington DC: American Psychiatric Pub; 2013.
  • Sarstedt M, Mooi E. Cluster analysis. A concise guide to market research. NYC, NY: Springer; 2014. p. 273–324.
  • Creavin ST, Wisniewski S, Noel-Storr AH, et al. Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst Rev. 2016;1:CD011145.
  • Grimsmo A, Lohre A, Rosstad T, et al. Disease-specific clinical pathways - are they feasible in primary care? A mixed-methods study. Scand J Prim Health Care. 2018;36(2):152–160.
  • Gupta SK, Nayak RP. Off-label use of medicine: Perspective of physicians, patients, pharmaceutical companies and regulatory authorities. J Pharmacol Pharmacother. 2014;5(2):88–92.
  • van Dyck CH. Anti-amyloid-β monoclonal antibodies for Alzheimer's disease: pitfalls and promise. Biol Psychiatry. 2018;83(4):311–319.
  • Roostaei T, Nazeri A, Felsky D, et al.; Alzheimer’s Disease Neuroimaging Initiative (ADNI). Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer's disease. Mol Psychiatry. 2017;22(2):287–295.
  • de Waard CS, Poot AJ, den Elzen WPJ, et al. Perceived doctor-patient relationship and satisfaction with general practitioner care in older persons in residential homes. Scand J Prim Health Care. 2018;36(2):189–197.
  • O’Malley K, Laher M, Cusack B, et al. Clinical pharmacology and the elderly patient. In: Denham M.J., editor. The treatment of medical problems in the elderly. Current status of modern therapy., vol 3. Springer: Dordrecht, 1980.
  • Köhler S, Buntinx F, Palmer K, et al. Depression, vascular factors, and risk of dementia in primary care: a retrospective cohort study. J Am Geriatr Soc. 2015;63(4):692–698.
  • Koch T, Iliffe S, Evidem Programme. The role of primary care in the recognition of and response to dementia. J Nutr Health Aging. 2010;14(2):107–109.
  • Keady J. The dynamics of dementia: a modified grounded theory study [Dissertation].University of Wales: Bangor, 1999.
  • Bunn F, Goodman C, Sworn K, et al. Psychosocial factors that shape patient and carer experiences of dementia diagnosis and treatment: a systematic review of qualitative studies. PLoS Med. 2012;9(10):e1001331.